The All Wales SACT Group collaborates with a range of national groups. Key groups include:
SACT Nurse Forum
(TOR to be added in due course)
The SACT Nurse Forum has been established to provide nurses from across Wales an opportunity to share best practice through collaboration and to collectively inform the development of practice and workforce standards. The forum is chaired by Dr Rosie Roberts (Velindre NHS Trust). For further information please contact Rosie via the Cancer Network's generic email: wcn.walescancernetwork@wales.nhs.uk
Genomics
The Wales Cancer Network has set up the All Wales Genomics Oncology Group (AWGOG) to facilitate a multidisciplinary and coordinated national approach to the development and implementation of oncology-specific genomic services provided by the All Wales Medical Genomics Service (AWMGS).
For further information about Genomics and AWGOG, please CLICK HERE.
AOS
The All Wales AOS Group was established by the Wales Cancer Network and aims to provide a strategic lead for national acute oncology priorities and a forum for the ratification of All Wales developments enabling a coordinated approach, for example in the development of AOS datasets, pathways, documents and support tools in order to ensure a standardised, cohesive acute oncology service for Wales.
For further information about AOS and the All Wales AOS Group, please CLICK HERE.
All Wales Therapeutics and Toxicology Centre (AWTTC)
AWTTC is an NHS Wales organisation that works with patients, carers, patient organisations, healthcare professionals, the pharmaceutical industry, Welsh Government and other relevant UK organisations to recommend and ensure appropriate and effective use of medicines.
For further information about AWTTC, please CLICK HERE.
All Wales Horizon Scanning Group
(Terms of Reference)
This group is constituted by members of AWTTC, AWGOG, histopathology and pharmacists representing the different specialities and health boards across Wales. They meet once a month to discuss treatments that are being proposed to NICE for approval and go through the possible impact these will have in terms of testing required, service provision, financial costs, and place within the current treatment pathway. This allows NHS Wales to be ready to deliver the new treatment as quickly as possible from the moment NICE approves it.
All Wales Bi-specific Antibody Sub - Group
(TOR to be added in due course)
The All Wales Bi-specific Antibody Sub-Group has been established by the Cancer Network as a subgroup of the All Wales Systemic Anti-Cancer Therapy (SACT) Group. It aims to provide a forum for sharing best practice and develop tools and guidelines to support local services to manage the safe introduction of these new medicines into clinical practice. The group will also provide advice and a strategic steer for Bi- specific antibodies enabling a coordinated approach to service provision across Wales.
Distribution List
Please follow the below link to the Distribution List form. This should take you less than a minute to complete. By completing this form you will be entered onto Wales Cancer Network's directory of staff, and will be contacted usually by email on topics that may interest you. Your information will be held securely by the Wales Cancer Network and will not be shared or distributed. The information held will be used only by Wales Cancer Network staff.
Click here for the Distribution List